{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:02:40Z","timestamp":1793905360922,"version":"4.8.0"},"reference-count":20,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4011,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1998,5]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> By using an immunoradiometric method with a stated detection limit of \u22641 IU\/l (stated normal reference limit in adults 3.7\u201316 IU\/l) we determined EDTA\u2010plasma erythropoietin (EPO) in 58 patients with polycythaemia vera (PV) and 49 patients with essential thrombocythaemia (ET). At the time of blood sampling, 20 of the PV patients were newly diagnosed and untreated, 23 were treated by phlebotomy only, and 30 also received myelosuppressive treatment (with 32P, hydroxyurea or alpha\u2010interferon). Of the ET patients 24 were untreated and 28 received myelosuppressive therapy. For comparison plasma EPO was also determined in 10 patients with pseudopolycythaemia (PP). In this latter group the results for plasma EPO agreed well with the cited normal reference limits. The majority of untreated PV patients (12\/20) had undetectable plasma EPO concentration, and the remainder all had values below the lower normal reference limit. Plasma EPO in PV was not significantly influenced by phlebotomy therapy. Twelve of the 24 untreated ET patients (50%) had plasma EPO values below the reference interval (undetectable in 2 patients). The mean EPO concentration was significantly lower in PV patients receiving phlebotomy therapy than in patients with untreated ET. In the total material of PV and ET treated with myelosuppressive agents the PV patients showed significantly lower values for EPO concentration than did patients with ET. The present results support the view that EPO measurements by high\u2010detectability methods are diagnostically useful and should be included in the panel of new criteria for the diagnosis of PV.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1998.tb01040.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T09:05:30Z","timestamp":1279443930000},"page":"278-282","source":"Crossref","is-referenced-by-count":48,"title":["Plasma erythropoietin by high\u2010detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia"],"prefix":"10.1111","volume":"60","author":[{"given":"Jan","family":"Carneskog","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Kutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Wadenvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per\u2010Arne","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Lindstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90750-2"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607313150503"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1992.tb02999.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1093\/clinchem\/38.9.1752","article-title":"Rapid and sensitive method for erythropoietin determination in serum","volume":"38","author":"Tanebe M.","year":"1992","journal-title":"Clin Chem"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.1995.tb01239.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/clinchem\/38.5.758","article-title":"Performance of an immunoradiometric assay of erythropoietin and results for specimens from anemic and polycythemic patients","volume":"38","author":"Andre M.","year":"1992","journal-title":"Clin Chem"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1993.tb00636.x"},{"issue":"1","key":"e_1_2_1_9_2","first-page":"87","article-title":"The diagnostic criteria of polycythaemia rubra vera","volume":"22","author":"Pearson TC","year":"1996","journal-title":"Leuk Lymph"},{"key":"e_1_2_1_10_2","first-page":"123","article-title":"Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols","volume":"23","author":"Berk PD","year":"1986","journal-title":"Semin Hematol"},{"key":"e_1_2_1_11_2","first-page":"177","article-title":"Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group","volume":"23","author":"Murphy S.","year":"1986","journal-title":"Semin Hematol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1973.tb01792.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1996.tb01335.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.1340459"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1994.tb55709.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830110110"},{"key":"e_1_2_1_17_2","first-page":"307","article-title":"Polycythemia rubra vera","volume":"22","author":"Bilgrami S.","year":"1995","journal-title":"Semin Oncol"},{"key":"e_1_2_1_18_2","first-page":"423","article-title":"Plasma erythropoietin in essential thrombocythaemia","volume":"35","author":"Viala JJ","year":"1993","journal-title":"Nouv Rev Fr Hematol"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1995.tb00273.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609074359"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609074366"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1998.tb01040.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1998.tb01040.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T22:00:19Z","timestamp":1698444019000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1998.tb01040.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,5]]}},"alternative-id":["10.1111\/j.1600-0609.1998.tb01040.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1998.tb01040.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5]]}}}